These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36045068)

  • 21. Contribution of respiratory syncytial virus, influenza and parainfluenza viruses to acute respiratory infections in San Luis Potosí, Mexico.
    Noyola DE; Arteaga-Domínguez G
    Pediatr Infect Dis J; 2005 Dec; 24(12):1049-52. PubMed ID: 16371864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4.
    Templeton KE; Scheltinga SA; Beersma MF; Kroes AC; Claas EC
    J Clin Microbiol; 2004 Apr; 42(4):1564-9. PubMed ID: 15071005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The return of RSV during the COVID-19 pandemic.
    Ferrero F; Ossorio MF; Rial MJ
    Pediatr Pulmonol; 2022 Mar; 57(3):770-771. PubMed ID: 34951156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and Clinical Course of Respiratory Viral Coinfections in Children Aged 0-59 Months.
    Nitsch-Osuch A; Kuchar E; Topczewska-Cabanek A; Wardyn K; Życińska K; Brydak L
    Adv Exp Med Biol; 2016; 905():17-23. PubMed ID: 26801151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decline of RSV-specific antibodies during the COVID-19 pandemic.
    den Hartog G; van Kasteren PB; Schepp RM; Teirlinck AC; van der Klis FRM; van Binnendijk RS
    Lancet Infect Dis; 2023 Jan; 23(1):23-25. PubMed ID: 36463892
    [No Abstract]   [Full Text] [Related]  

  • 26. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic.
    Bermúdez Barrezueta L; Matías Del Pozo V; López-Casillas P; Brezmes Raposo M; Gutiérrez Zamorano M; Pino Vázquez MA
    Infection; 2022 Aug; 50(4):1001-1005. PubMed ID: 35316529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study.
    Bigliardi S; Morselli M; Potenza L; Riva G; Coluccio V; Maccaferri M; Paolini A; Colaci E; Fantuzzi V; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Lugli E; Gilioli A; Quadrelli C; Vallerini D; Barozzi P; Lagreca I; Marasca R; Narni F; Franceschini E; Codeluppi M; Mussini C; Luppi M; Forghieri F
    Ann Hematol; 2015 Nov; 94(11):1931-4. PubMed ID: 26204825
    [No Abstract]   [Full Text] [Related]  

  • 29. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
    Liang B; Munir S; Amaro-Carambot E; Surman S; Mackow N; Yang L; Buchholz UJ; Collins PL; Schaap-Nutt A
    J Virol; 2014 Apr; 88(8):4237-50. PubMed ID: 24478424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluctuations in influenza virus and respiratory syncytial virus infections in children before, during and after the COVID-19 pandemic.
    Liang Y; Hu M; Zhang M; Du B; Hou L; Zhang X; Zhang W
    J Hosp Infect; 2024 Jan; 143():218-220. PubMed ID: 37757918
    [No Abstract]   [Full Text] [Related]  

  • 32. Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan.
    Madaniyazi L; Seposo X; Ng CFS; Tobias A; Toizumi M; Moriuchi H; Yoshida LM; Hashizume M
    Jpn J Infect Dis; 2022 Mar; 75(2):209-211. PubMed ID: 34470964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex).
    Fan J; Henrickson KJ; Savatski LL
    Clin Infect Dis; 1998 Jun; 26(6):1397-402. PubMed ID: 9636869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay.
    Osiowy C
    J Clin Microbiol; 1998 Nov; 36(11):3149-54. PubMed ID: 9774555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Epidemiology of Respiratory Syncytial Virus in New York City during the Coronavirus Disease-2019 Pandemic Compared with Previous Years.
    Halabi KC; Saiman L; Zachariah P
    J Pediatr; 2022 Mar; 242():242-244.e1. PubMed ID: 34728233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory syncytial virus and influenza surveillance in schoolchildren seen at a children's hospital over 2 months of the second semester of 2021.
    Orqueda AS; Lucion MF; Juárez MV; Barquez R; Stach P; Nievas A; Losi LF; Suárez RF; Romero Bollón L; Pejito MN; Mistchenko AS; Gentile Á
    Arch Argent Pediatr; 2022 Aug; 120(4):269-273. PubMed ID: 35900954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycoplasma pneumoniae pneumonia and respiratory syncytial virus infection in Japan during the severe acute respiratory syndrome coronavirus 2 pandemic.
    Fujita J
    Respir Investig; 2021 Jan; 59(1):5-7. PubMed ID: 33279448
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report.
    Shi B; Xia Z; Xiao S; Huang C; Zhou X; Xu H
    Clin Pediatr (Phila); 2020 Jul; 59(8):823-826. PubMed ID: 32292053
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infant asthma: sole role of respiratory syncytial virus?].
    Brouard J; Nimal D; Vabret A; Arion A; Bach N; Duhamel JF; Freymuth F
    Arch Pediatr; 2006 Jun; 13(6):801-3. PubMed ID: 16690281
    [No Abstract]   [Full Text] [Related]  

  • 40. During the COVID-19 pandemic where has respiratory syncytial virus gone?
    Di Mattia G; Nenna R; Mancino E; Rizzo V; Pierangeli A; Villani A; Midulla F
    Pediatr Pulmonol; 2021 Oct; 56(10):3106-3109. PubMed ID: 34273135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.